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Chronic rhinosinusitis (CRS) is a clinical syndrome associated with persistent inflammation 
of the sinonasal mucosa. It consists of a heterogenous group of inflammatory diseases 
either accompanied by polyp formation (CRSwNP) or without polyps (CRSsNP) (Fokkens 
et al. 2012). 
CRS is a very common condition and its prevalence is estimated to be 10-12% in Europe 
and the United States of America (Jarvis et al. 2012; Palmer et al. 2019). 
The etiology of CRS is complex and multifactorial but at its center lies the concept of 
persistent mucosal inflammation. Research in the last 20 years has contributed to further 
understanding of this chronic upper airway disease. However, the precise causes are not 
fully understood. The proposed mechanisms for this enduring inflammation of the 
sinonasal mucosa include obstruction of the ostiomeatal complex, impaired mucociliary 
clearance, distortion of the nasal microbiome, biofilm formation and atopy (van 
Cauwenberge et al. 2006). 
1.1 Demographics of  CRS 
CRS is amongst the most common conditions encountered in medicine and is associated 
with substantially impaired quality of life, reduced workplace productivity and significant 
treatment costs (Chivato et al. 2012; Ference et al. 2015; Erskine et al. 2017). 
It is slightly more common among women and the incidence peaks between the ages of 45-
54. There appear to be sex differences also, as CRSsNP is commoner in women and 
CRSwNP is commoner in men (Beule 2015). 
CRS is strongly associated with chronic conditions of the upper and lower airway tract, 
particularly with asthma. Other airway conditions include bronchitis, pneumonia, 
obstructive sleep apnea (OSA) and gastroesophageal reflux disease (Tan et al. 2013b). 
In Germany, there are currently no reliable epidemiological data for the prevalence of CRS 
(Stuck et al. 2018). In Europe, the first population-based epidemiologic study in 2011 
estimated the prevalence of CRS among adults at 10.9% with a significant geographical 
variation across the continent. The lowest prevalence (6.9%) was reported in Helsinki 
(Finland) and Brandenburg (Germany) and the highest (27.1%) in Coimbra (Portugal) 
(Jarvis et al. 2012). 
In the United States of America, the prevalence is estimated at 11.5% of adults (Palmer et 
al. 2019) placing CRS among the ten most costly medical conditions with 11.1 million 




In Asia, epidemiological studies have estimated the overall prevalence in China at 8% (Shi 
et al. 2015) and 7% in Korea respectively, with a significant rise documented within a 
twenty-year time period (Min et al. 1996). 
1.2 Clinical presentation 
CRS in adults is defined according to the latest European Position Paper on Rhinosinusitis 
and Nasal Polyps (EPOS) as symptomatic inflammation of the sinonasal mucosa that 
persists for at least twelve weeks with no complete resolution. It is characterized by two or 
more symptoms, one of which should be either nasal blockage/obstruction/congestion or 
nasal discharge (anterior/posterior nasal drip) – with or without facial pain/pressure – with 
or without reduction or loss of smell. Evidence of mucosal inflammation should be 
documented using either nasal endoscopy or computed tomography of the nasal sinuses 
(Fokkens et al. 2012). 
 
Table 1: EPOS 2012 diagnostic criteria for CRS 
Criteria for the diagnosis of chronic rhinosinusitis with or without polyps 
Inflammation of the nose and paranasal sinuses by two or more symptoms, one of which 
should be either nasal blockage/obstruction/congestion, oronasal discharge 
(anterior/posterior nasal drip) 
+/- facial pain or pressure 
+/- reduction or loss of sense of smell 
Supported with either: 
endoscopic signs of disease including polyps, edema or mucopurulent discharge 
or radiologic evidence of changes in the sinuses or ostiomeatal complex on computed 
tomography scan (CT) 
One of the two cardinal symptoms (nasal blockage and nasal discharge) should be present in order to 
diagnose a patient with CRS (Fokkens et al. 2012). 
 
This definition and classification has been proposed by consensus of an expert group on 
chronic rhinosinusitis and allergic rhinitis in 2012, in an aim to standardize previous 
inconsistencies regarding the disease. 
CRS is typically classified into two clinically distinguishable phenotypes: chronic 
rhinosinusitis without nasal polyps (CRSsNP) and chronic rhinosinusitis with nasal polyps 
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(CRSwNP). The majority of patients suffer from CRSsNP (75-80%) and the rest 20-25% 
from CRSwNP. According to the proposed diagnostic plan, polyps should be 
endoscopically visualized at least in the middle meatus in order to be classified as 
CRSwNP. Another rare form of CRS is allergic fungal sinusitis (AFS), which is commonly 
characterized by a profound growth of a fungal organism, such as Aspergillus or Alternaria 
species. These fungi cause a local immune reaction predominantly with eosinophilia and 
clinically distinct due to the presence of thick mucin (Tyler and Luong 2018). 
In general, the clinical presentation and symptoms of CRSsNP and CRSwNP overlap. 
There are common inflammatory pathways in both forms, but it appears from research 
done in the last years that both forms are underlined by distinct immunopathological 
mechanisms and patterns. 
1.3 Common inflammatory changes 
1.3.1 Structural changes in CRS 
The nose and paranasal sinuses undergo a structural metamorphosis in CRS that appears 
radiologically and intraoperatively. Inflammation causes edema and swelling of the nasal 
mucosa, resulting in obstruction of the sinus ostia and mucus retention (Naclerio et al. 
2010). 
1.3.2 Mucosal remodeling and epithelial dysfunction 
The respiratory epithelium provides a crucial barrier between the internal and external 
environment, as it is the site of primary attachment of inhaled irritants and pathogenic 
organisms. The concept of a dysfunctional interaction between host and environment is 
central in explaining CRS etiology and pathogenesis (Tan et al. 2010). The ability of the 
respiratory epithelium to provide protection depends partly on the physical ability of the 
epithelium to form tight junctions between cells preventing the entrance of pathogens. 
Tight junction-associated proteins and junctional adhesion molecules are central in this 
process and have been shown to be impaired in both forms of CRS in a process called 
epithelial-to-mesenchymal transition (EMT), a process occurring in mucosa during 
inflammation and ongoing repair (Khalmuratova et al. 2017). 
During this process, there is a profound change in the morphology and junctional 
connection of epithelial cells to one another. Once activated, they proliferate and transform 
into mesenchymal cells. They gain migratory function and synthesize collagens and other 
matrix proteins, resulting in an expansion of the basement membrane. This mucosal 
remodeling impairs its normal protective function. The exact causes of this transition from 
epithelial to mesenchymal cells in CRS are not known but pathogens, irritants such as 
smoke, allergens and hypoxia are all supposed to induce this process (Zhang et al. 2016). 
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Defects in the mechanical and immunological components of the epithelial barrier function 
are thought to play a central role in enabling foreign antigens to stimulate an immune 
response. An impaired epithelial immune barrier function makes the sinonasal mucosa 
more susceptible to antigenic exposure and is thought to be a significant causative 
mechanism in patients with CRS (Tieu et al. 2009). 
In addition to the tight junctions between epithelial cells, mucociliary clearance of the 
upper airway has a major function in protecting against airborne pathogens. Successful 
clearance depends upon two factors; effective ciliary movement and regulation of the 
airway mucus layer. The coordinated beating of cilia directs mucus and trapped particles 
towards sinus ostia and eventually to the nasopharynx. The significance of this coordinated 
and efficient mucociliary clearance in maintaining paranasal sinus health is confirmed in 
patients and animal models with ciliary function defects or abnormal mucus production 
(London and Lane 2016). 
Poor mucociliary clearance due to impaired cilia beating is a common finding in CRS. In 
such patients there is a compromised response to irritants such as allergens and 
microorganisms that usually stimulate and enhance cilia activity. This leads to a vicious 
cycle of stasis, further microbial colonization and chronic inflammation (Passàli et al. 1999). 
1.3.3 Nasal microbiota 
Changes in the nasal microbiota have also been implicated in the development of CRS. A 
distortion of the commensals in the microbiome of the nose and paranasal sinuses is 
thought to promote recurrent infections, and activate innate and adaptive immune 
responses. Several studies have shown a significant depletion in the microbiota diversity in 
patients with CRS compared to healthy controls suggesting that an imbalance (or dysbiosis) 
in the microbial community has a role in the development of CRS (Boase et al. 2013; 
Biswas et al. 2015). 
Bacterial diversity and the composition of the sinonasal microbiome have been shown to 
be predictors of surgical outcome in cases of CRS, with patients having a better surgical 
outcome if there were more diverse bacterial communities present at the time of surgery 
(Ramakrishnan et al. 2015). On the contrary, increased bacterial load with Staphylococcus 
aureus and the presence of Staphylococcus aureus biofilms and superantigens are associated 
with eosinophilic inflammation and Th2 skewed response across all types of CRS 
(Foreman et al. 2011). A significant increase in the local immunoglobulin (IgE) levels has 
been shown, independent of serum IgE, supporting the notion that these bacterial 
superantigens can activate local B- and plasma cells (van Zele et al. 2004). 
Not all studies agree with the causative role of the microbiota in the development of the 
disease. Researchers have indicated that patients with CRS show an abnormal reaction with 
prolonged inflammation even in the presence of normal bacterial communities (Aurora et 
al. 2013). The link between the sinonasal microbiome and its effect on CRS is complex due 
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to the diverse nature of the disease and the distinct biogeographical patterns of bacterial 
communities among different patient populations (Biswas et al. 2015; Mahdavinia 2018). 
The community of bacteria has also been shown to be altered in the nose in the presence 
of allergic disease. This leads to exaggerated immune responses, promoting chronic 
inflammation (Mahdavinia 2018). 
1.4 Different mechanisms – Innate and acquired immunity 
Respiratory epithelial cells have a central role in activating sinonasal innate immunity. 
These cells are stimulated once they recognize pathogenic molecular patterns as well as 
damage-related molecular patterns in their vicinity. Once activated, respiratory epithelial 
cells release a milieu of signaling molecules and cytokines that coordinate the interaction 
with other infiltrating and local inflammatory cells (Ooi et al. 2010). 
Cytokines facilitate the communication between cells of the immune system, thus playing a 
central role in the inflammatory response present in chronic rhinosinusitis. Riechelmann et 
al. (2005) investigated the expression of various cytokines in the sinonasal secretions of 
patients and compared it to normal controls. They found that all of the investigated 
cytokines were considerably elevated in the CRS cohort.  
There is substantial heterogeneity in the immunological mechanisms between CRSwNP 
and CRSsNP, with different inflammatory cell profiles and T-cell patterns. These distinct 
mechanisms originate from innate immune cells responding and interacting with the 
acquired immune system in different ways. Cells of the innate immune system contribute to 
the transition from an acute inflammatory response to sustained chronic inflammation. 
These cells including macrophages, dendritic cells, endothelial and epithelial cells, shift the 
inflammatory pathway into either a T helper type 2- (Th2) skewed inflammation or T 
helper type 1 (Th1) response (Ramanathan and Lane 2007). Th1 cytokine immune 
responses are typically associated with reactions against bacterial pathogens, whereas Th2 
immune responses are classically seen in allergic and antiparasitic immune reactions. Within 
a healthy organism, both Th1 and Th2 immune responses coexist. However, their balance 
has been shown to be altered in patients with CRS as well as allergic disease (Cousins et al. 
2008; Daines und Orlandi 2010). 
CRSsNP is associated with a response that drives naive T cell differentiation into a Th1 
dominant inflammation, with high levels of interferon gamma (IFN-γ) as well as 
transforming growth factor beta (TGF-β). This TGF-β pathway is upregulated in patients 
with CRSsNP and downregulated in CRSwNP. This is reflected histologically as fibrosis, 
basement membrane thickening and excessive collagen deposition, findings that are evident 
from the early stages of the disease in CRSsNP (van Bruaene et al. 2009). TGF-β also 
regulates the function of immune cells, suppressing the activation of T cells and antibody 
secretion by B cells. In CRSsNP, sinonasal mucosa is swollen and profuse secretions are 
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observed, often with pus, since hyperplasia of the submucosal glands is more common in 
CRSsNP (Kim et al. 2015). 
CRSwNP is associated with a Th2 eosinophilic inflammation with an overexpression of 
eosinophils and related inflammatory products. It includes high interleukin-4 (IL-4), 
interleukin-5 (IL-5) and interleukin-13 (IL-13) levels, high eosinophil cationic protein 
(ECP), high IgE levels, upregulation of T-cell activation marker soluble interleukin-2 (IL-2) 
receptor alpha, deficit in regulatory T-cells and increased activity of T-helper cells. CRSsNP 
is associated with a Th1 inflammation and no deficit in regulatory T-cells (van Zele et al. 
2006; Zhang et al. 2008). Edema formation is a prominent feature of CRSwNP, as well as 
formation of pseudocysts and lack of collagen production. 
However, there are geographical exceptions to the above Th2 polarization in CRSwNP. It 
has been shown that patients from South China and other Asian regions develop nasal 
polyps with a neutrophilic cellular pattern, in the absence of the IL-5 activation (Zhang et 
al. 2006). 
In patients with allergic rhinitis, the production of IL-4 activates naïve T lymphocytes 
promoting their differentiation into Th2 CD4+ cells. In this mechanism of 
immunoglobulin class switching, mature B cells shift production from immunoglobulin M 
(IgM) to IgE antibodies. The class switching process is modulated by various cytokines, 
primarily IL-4 and IL-13 produced by activated T cells. As a result, stimulated plasma cells 
induce IgE release, with the subsequent allergic response upon allergic exposure (Stone et 
al. 2010). 
1.5 Treatment options in CRS 
CRS is a challenging disease to treat. Common treatment options include intranasal 
(topical) corticosteroids, saline irrigation, antibiotics and oral steroids (Fokkens et al. 2012; 
Head et al. 2016; Luk and DelGaudio 2017). 
Patients with extensive disease or refractory cases progress to functional endoscopic sinus 
surgery (FESS), with continued medical therapy thereafter (Hellings et al. 2017). The array 
of endoscopic endonasal sinus operations has considerably increased in the last 30 years. 
Improved endoscopic techniques along with advances in imaging systems allow surgeons 
to perform a variety of endonasal procedures including infundibulotomy, ethmoidectomy 
or extended surgery of the skull base, frontal and sphenoid sinus. The objective of 
endonasal sinus surgery is to improve drainage of nasal sinuses and remove relevant foci of 
disease while preserving normal mucosa as much as possible (Weber and Hosemann 2015). 
These treatment strategies focus on symptomatic control by reducing the mucosal 
inflammation and bacterial burden of paranasal sinuses. Although they are effective for the 
majority of patients (Stuck et al. 2018), there is still a significant proportion of patients who 
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respond only partly to these therapeutic interventions, particularly patients with CRSwNP 
(Hopkins et al. 2009; DeConde et al. 2017).  
1.6 Allergy and allergic rhinitis 
An allergic response is an abnormal reaction of the human body when in contact with 
normally harmless substances that are called allergens. It is initiated by specific 
immunologic mechanisms. Upon exposure to an allergy source, type I hypersensitivity 
reaction against that allergen occurs. The antigen is presented by a Th2 lymphocyte, which 
in terms initiates the production of IL-4. These cells interact and activate B cells to begin 
producing large quantities of IgE antibodies that circulate in the blood, eventually binding 
to an IgE-specific receptor, the Fc epsilon receptor I (FcεRI) on the surface of mast cells 
and basophils. The individual at this stage is said to be sensitized to the allergen. Upon a 
secondary exposure to the same allergen, the allergen is attached to IgE molecules that are 
bound on the surface of granulocytes. Cross-linking of the IgE and Fc receptors occurs 
activating mast cells and basophils to undergo degranulation, releasing histamine and an 
array of other pro-inflammatory mediators such as cytokines, leukotrienes, interleukins, 
prostaglandins and growth factors into the surrounding tissue. This directly evokes a large 
variety of tissue responses, including vasodilation, increased vascular permeability, 
increased adhesion molecule expression, mucous secretion and smooth muscle contraction. 
Depending on the immune system of the individual, the allergen and the entry point, the 
symptoms can be systemic or localized to particular body systems (Denburg 2013). 
Allergic diseases rank at first place among chronic diseases in childhood and adolescence in 
Germany, with 20-25% of individuals being currently affected by one of the atopic 
diseases. The three most important conditions are atopic eczema/dermatitis, allergic 
rhinitis and asthma. Interviews and questionnaires relating to doctor diagnosed allergic 
diseases in Germany yielded a prevalence of 13.2% for atopic dermatitis, 10.7% for allergic 
rhinitis and 4.7% for asthma in children and adolescents (Schlaud et al. 2007). The 
prevalence of allergic disease (similar to other allergic conditions) affecting both adults and 
children is reported to be increasing. This trend has been shown worldwide as well as 
specifically in Germany (Maziak et al. 2003; Arbes et al. 2005).  
The dramatic increase in the prevalence of allergic disease that has been documented in the 
last 50 years is thought to be the result of changes in environmental factors and coincides 
with our increasingly modern Westernized lifestyles. According to the “hygiene 
hypothesis”, alteration of the microbial exposure along with the increasing use of 
antibiotics predisposes individuals to allergic disease. This is specifically true during early 
life as it can strongly influence immune system maturation (Daley 2014; Burbank et al. 




In addition, epidemiologic studies have demonstrated that urbanization, which is linked to 
elevated exposure to air pollutants is associated to the increasing incidence of respiratory 
allergic diseases and bronchial asthma observed in most industrialized countries. Airborne 
air pollutants, which have increased in the atmosphere, are thought to enhance IgE-
mediated response to aeroallergens and promote airway inflammation (D’Amato et al. 
2016). 
Allergic rhinitis involves hypersensitivity symptoms occurring in the nose and paranasal 
sinuses. Symptoms include nasal blockage, rhinorrhea, nasal itching and sneezing. The 
majority of patients experience accompanying ocular symptoms such as tearing, itching and 
redness. Allergic rhinitis is the commonest cause of reversible nasal congestion. Its 
prevalence is estimated between 10% and 20% depending on geographical region, however 
it is thought that a significant proportion of cases remain undiagnosed (Settipane and 
Charnock 2007). The frequency of allergic rhinitis increases with age, and the majority of 
patients (80%) will experience their first symptoms before the age of 20. In children there 
is a higher incidence amongst boys, but in adults, it affects both sexes equally (Skoner 
2001). A large demographic study regarding allergic diseases in adult subjects living 
in Germany published in 2013 identified a lifetime prevalence of 14.8% for allergic rhinitis 
(Langen et al. 2013). 
Allergic rhinitis, similar to other respiratory-tract allergies has a considerable impact on the 
quality of life of patients and appears to affect them to the same extent as that of other 
chronic diseases such as diabetes and cardiovascular disease (Petersen 2008). 
Allergic rhinitis appears to have a strong genetic component as the tendency to develop 
Th2 lymphocyte immune responses, with IgE and mast cells is inherited by atopic patients. 
Once sensitization has occurred, subsequent exposures to the same allergen generate a 
cascade of events that result in allergic symptoms. 
Conventionally, allergic rhinitis as been classified either as perennial or seasonal, according 
to the timing and duration of the allergen exposure (Gentile et al. 2013). Approximately 
20% of all cases were thought to be strictly seasonal, 40% perennial and 40% mixed 
(perennial with seasonal exacerbations). The commonest causative allergens for seasonal 
allergic rhinitis are early blossoming plants such as birch, alder and hazel and pollen of 
grass or rye. The commonest allergens contributing to perennial allergic rhinitis include 
house-dust mite, molds, and animal dander from cats, dogs and horses (Greiwe and 
Bernstein 2019). However, some patients that are sensitized to seasonal allergens 
experience symptoms throughout the year and some that are sensitized to perennial 
allergens experience symptoms only during some months of the year. Because of the 
limitations of the above classification from a therapeutic standpoint and its poor 
association with clinical symptoms, a new Allergic Rhinitis and its Impact on Asthma 
(ARIA) classification was proposed in 2001 by the World Health Organization. This new 
Introduction 9 
  
classification, categorizes allergic rhinitis according to severity and symptom duration 
(Johansson et al. 2004b; Bauchau and Durham 2005). 
The only up-to-date publication regarding allergic rhinitis that exists in Germany from the 
most recent Health Survey, reported that based on blood samples of 7025 individuals 
33.6 % of the participants were sensitized to common aeroallergens. 22.0% of participants 
were sensitized to pollen of grass, 19.0% were sensitized to pollen of early blossoming 
plants, 15.9% to house dust mite, 10.0% to animal dander and 4.6% to fungi (Haftenberger 
et al. 2013). 
The diagnosis of allergic rhinitis is based on the demonstration of the production of serum 
allergen specific immunoglobulin E (sIgE) or positive skin-prick test (SPT) in patients with 
a positive history of allergic symptoms. In some cases, especially when it involves seasonal 
allergic rhinitis, a nasal provocation test can be used to confirm the clinical diagnosis. 
Perennial allergic rhinitis is often more challenging to detect than seasonal allergic rhinitis 
due to the overlap with chronic rhinosinusitis, respiratory infections, and vasomotor 
rhinitis (Seidman et al. 2015). 
1.7 Treatment options in allergic rhinitis 
The treatment of allergic rhinitis consists of 3 major pillars: a. Environmental control 
measures and avoidance, b. Pharmacological management and c. Immunotherapy. 
Environmental control measures and avoidance of allergen exposure can be applied in all 
types of allergens. Patients are actively engaged in using strategies that aim to minimize 
exposure to specific allergens and thus reduce symptoms of allergic rhinitis. These 
approaches for minimizing exposure to various seasonal and perennial allergens can be 
quite challenging, expensive and often impractical (Seidman et al. 2015). 
Several pharmacologic options for the management of allergic rhinitis exist including oral 
and intranasal corticosteroids, oral and topical antihistamines, decongestants, intranasal 
anticholinergics, and leukotriene receptor antagonists (Fokkens et al. 2012). The use of 
intranasal corticosteroids is the most effective symptomatic treatment of allergic rhinitis, 
which decreases all symptoms, including ocular ones. It is currently the mainstay of 
symptomatic treatment and is used alone or in combination with intranasal antihistamines.  
Antihistamines have been shown to significantly reduce nasal congestion, conjunctivitis, 
sneezing and rhinorrhea when used orally or topically. Oral antihistamines have been used 
for more than 50 years, providing relief from allergic symptoms. Second generation oral 
antihistamines have been developed to reduce sedation and lower the anticholinergic side 
effects with enhanced reduction of symptoms such as runny nose, nasal itching and 
sneezing compared to older histamine receptor antagonists (Kawauchi et al. 2019). 
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The combination of topical corticosteroid with intranasal antihistamine has been shown to 
be superior to monotherapy in providing control over allergic rhinitis. Alternative 
therapies, such as homeopathy, probiotics, herbal preparations and acupuncture have 
produced some positive results in small trials but there is still insufficient data, and are thus 
not recommended by Allergic Rhinitis and its Impact on Asthma (ARIA) (Schröder et al. 
2017). 
Immunotherapy should be considered in all patients with moderate or severe persistent 
allergic rhinitis. Immunotherapy, which has been shown to be safe in children and adults, is 
the only causal therapy that can change the natural course of allergic rhinitis and can 
prevent exacerbations. It entails a small amount of allergen extract administered 
sublingually or subcutaneously over the course of three to five years (Pfaar et al. 2014). 
1.8 Allergic rhinitis and CRS 
CRS and allergy to aeroallergens are two of the most common reasons for presentation of 
patients to the ear nose throat (ENT) practitioner. The two entities may be independent, 
but often they coexist in the same patient (Geißler and Guntinas-Lichius 2015). 
On a microscopic level, the presence of allergy has been shown to alter the sinus mucosa 
consistency (Passàli et al. 1995) and the cilia of the respiratory epithelium (Bozzo et al. 
2005). In addition, it has been reported that allergic subjects tend to have 
abnormal nasal airflow and mucociliary clearance values compared to healthy controls. 
These abnormalities were associated significantly with higher nasal sinus CT scores, thus 
predisposing patients to rhinosinusitis and sinonasal inflammation (Alho 2004). 
Evidence of susceptibility to (acute) sinusitis has also been shown on an experimental level. 
In a mouse model of sinusitis using intranasal inoculation with Staphylococcus pneumonia, mice 
with ongoing nasal allergic inflammation had significantly more bacteria and more 
inflammation in their sinus mucosa (Blair et al. 2001). 
In human subjects, Baroody et al. (2008; 2012) showed an increase in vascular permeability 
associated with an eosinophilic influx into the ipsilateral maxillary sinus after nasal 
challenge with allergens. Similar results with sinus inflammation were detected by lavage 
sampling during the allergen season. 
Suzuki et al. (1999) identified similar results in a cellular and molecular level. The 
pathological features of paranasal sinus effusion and mucosa were compared between 
patients with chronic rhinosinusitis with and without an allergy. The number of activated 
eosinophils/neutrophils, and the concentration of IL-5 was higher in paranasal sinus 
effusion from patients with allergic sinusitis. 
On a clinical level, a cause and effect relationship between allergic rhinitis and CRS has 
been proposed for years, based mainly on epidemiological studies. For many studies 
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performed in the past, no direct comparison can be made, as they have often grouped 
together patients with CRSsNP and CRSwNP, had heterogeneity in their design, inclusion 
criteria used for the diagnosis of CRS and allergens studied (Terzakis and Georgalas 2017). 
Therefore, there is still controversy over disease causality and uncertainty whether atopic 
conditions can aggravate disease severity, accelerate its recurrence or just be a disease-
modifying factor. 
Two systematic reviews of the scientific literature performed in the last years (Georgalas et 
al. 2014; Wilson et al. 2014) as well as a study investigating whether specific allergen 
sensitization is correlated with sinonasal radiographic opacification (Brook et al. 2017) have 
questioned a direct causative link between allergy and CRS. They report no association 
between atopy status, disease severity or recurrence in patients with CRS. They question 
further the direct causality of allergy on CRS and indicate that there is no increase in the 
incidence of infectious rhinosinusitis during the pollen season in pollen-sensitized 
individuals. 
1.9 Hypothesis 
Although our understanding of the pathophysiological mechanisms of CRS has 
significantly improved, the relationship between CRS and allergic rhinitis to inhalant 
allergens remains unclear due to controversial findings and difficulties in comparing studies 
due to diversity in the methodologies. To further investigate this association, we conducted 
a retrospective study of all consecutive patients between November 2012 and November 
2016 who presented to our otorhinolaryngology clinic with evidence of CRS and had a 
positive screening test for inhalant allergy (SX1 radioallergosorbent test: RAST). 
We hypothesize that allergic inflammation would actively impair the normal sinus 
physiology in several ways, thus predisposing and exacerbating chronic rhinosinusitis. 
Allergic edema causing ostial obstruction and altering the normal drainage and ventilation 
of the sinuses would promote mucus accumulation and retaining of sinus secretions. This 
could impair ciliary movement, promoting bacterial growth within the sinuses, resulting 
into a chronic inflammation. We assumed that patients with a proven inhalant allergy 
would have more severe radiological evidence of disease compared to patients without an 
allergy. 
Secondarily, other factors such as polyposis, gender and asthma will be investigated 
whether they influence CRS severity. Finally, we will analyze whether the presence of 





A retrospective study of 938 consecutive patients who were referred to our clinic between 
November 2012 and November 2016 was performed. All of these patients presented with 
rhinological symptoms due to CRS and had a positive screening test for inhalant allergy 
(SX1 RAST). Patients were included in our study if there was a complete sinus workup at 
our institution, if they satisfied the inclusion criteria for the diagnosis of CRS based on the 
EPOS-2012 criteria and if they did not satisfy any other of the exclusion criteria. After 
applying these criteria, 195 patients were included. For a more detail presentation, see 
Table 2 and Figure 1. 
 
Table 2: Study exclusion criteria 
Exclusion Criteria 
Patient <18 years of age 
Incomplete sinus work-up 
Diagnosis not satisfying EPOS 2012 criteria 
Previous surgery to the sinuses and nasal septum 
Prior trauma to the nose and mid-face 
Congenital anatomical variations such as cleft lip 
Benign or malignant tumors of the nose and nasal sinuses 
Immunocompromised patients 
Inflammatory and autoimmune conditions 
 
 
We recorded demographic data, CRS subtype, asthma status and other relevant 
comorbidities. We performed extensive allergic diagnostics, including skin-prick testing and 
serum IgE measurements to all patients and when needed nasal provocation.  
In terms of the complete sinus workup, this included history taking, nasal endoscopy with 
30-degree endoscope and a computed tomography (CT) scan of the nasal sinuses available 
in electronic form in our database (PACS, General Electric, USA). The radiologic evidence 




All the allergy diagnostic was performed based on the 2014 guidelines of the German 
Society of Allergy and Immunology (Pfaar et al. 2014). 
2.1.1 Screening Test 
All our patients were initially seen in our general otorhinolaryngology clinic where an in vitro 
screening test for inhalant allergy (SX1 RAST) was performed. This investigation tests the 8 
most common aeroallergens that are present in the regional population. They are listed in 
table 3. Patients with a positive screening test (RAST 1 or above) were seen in our 
specialized allergy outpatient’s clinic. 
 
Table 3: Panel of aeroallergens tested for total IgE as initial serological screening (SX1 
RAST) 
Common name Species 
House dust mite Dermatophagoides pteronyssinus 
Dog Canis familiaris 
Cat Felis domesticus 
Timothy-grass Phleum pratense 
Cultivated rye  Secale cereal 
Fungi  Cladosporium herbarum 
Birch Betula pendula 
Mugworth Artemisia vulgaris 
 
 
ImmunoCAP® Total IgE measures IgE in human serum or plasma in concentrations 
between 0.1 to 100 kilo unit per litre (kU/L) stimulation. Serum total IgE levels greater 
than 0,35 kU/L were considered elevated, and thus a positive screening test. Table 4 lists 
the rating of RAST screening test based on the IgE levels. For the in vitro total serum IgE 













0 <0.35 Absent or undetectable allergen specific IgE 
1 0.35-0.69 Low level of allergen specific IgE 
2 0.70-3.49 Low to moderate level of allergen specific IgE 
3 3.50-17.49 Moderate level of allergen specific IgE 
4 17.50-49.99 Moderate to high level of allergen specific IgE 
5 50.00-100.00 High level of allergen specific IgE 
6 >100.00 Extremely high level of allergen specific IgE 
 
 
2.2 Skin prick test 
For those individuals with a positive screening test, an appointment in our specialized 
allergy outpatient’s clinic was followed. A detailed allergy-specific history was acquired, 
followed by skin prick testing (Table 5). Allergens, which are routinely tested in our allergy 
clinic, include extracts of tree pollen (birch, alder, hazel), grass pollen (cultivated rye, 
timothy-grass), weed pollen (ragweed, pellitory, ash), the two commonest house dust mites 
(Dermatophagoides pteronyssinus und Dermatophagoides farinae), three mold species (Alternaria 
alternata, Aspergillus fumigatus, and Cladosporium herbarum), dog and cat dander. Histamine was 
used as a positive control, and saline as a negative control. The test was read 20 minutes 
after applying the allergens. It was regarded as positive when the skin reacted with a wheal 
size of greater or equal to 3 mm greater than the negative control. We performed the 









Table 5: Allergens that are routinely tested by skin prick test in our clinic 
Common name                                   Species 
Birch                                                         Betula pendula 
Alder                                                        Alnus incana 
Hazel                                                        Corylus avellana 
Roggen                                                     Secale cereale 
Timothy-grass                                          Phleum pratense 
Ragweed                                                  Ambrosia artemisiifolia 
Pellitory                                                   Parietaria judaica 
Ash                                                          Fraxinus excelsior 
House dust mite                                      Dermatophagoides pteronyssinus 
House dust mite                                      Dermatophagoides farinae 
Mold                                                       Alternaria alternata 
Mold                                                      Aspergillus fumigatus 
Mold                                                      Cladosporium herbarum 
Dog dander                                           Canis familiaris 
Cat dander                                             Felis domesticus 
 
 
2.3 Specific Serum IgE 
After having a positive skin prick test, we tested specific serum IgE measurements in all 
our patients during their appointment in our specialized allergy clinic. For the in vitro 
specific serum IgE measurements we used the ImmunoCAP® System (Phadia AB, 
Uppsala, Sweden). This test enables an objective measurement of the circulating IgE 
antibodies to specific allergens in human serum or plasma thus allowing us to identify 




2.4 Nasal provocation 
In patients with house dust mite allergies, in those with discrepancies between medical 
history and skin prick test/specific IgE results, or multisensitized patients, a nasal 
provocation test (LETI, Barcelona, Spain) was used. We use the technique previously 
described (Riechelmann et al. 2003; Gosepath et al. 2005) with extracts administered 
intranasally in increasing concentrations of 1:10000, 1:1000, 1:100, 1:10, 1:1 with a waiting 
time of 15 minutes before each measurement. At each concentration, we measured nasal 
flow using acoustic rhinometry and documented clinical symptoms. 
Once the diagnostic work-up was performed, subjects were categorized as allergic, or non-
allergic. A concise definition of allergy is not uniformly accepted, but for this study our 
criteria for the diagnosis of allergic rhinitis was a positive history of allergic rhinitis 
symptoms combined with a matching positive skin prick test and elevated specific IgE 
levels for the same allergen. In some patients (23 out of 80) allergic rhinitis was additionally 
confirmed with a nasal provocation test as described above. 
2.5 Computed Tomography and the Lund Mackay scoring system 
Computed tomography (CT) scans of the nasal sinuses were scored using the Lund Mackay 
scoring system (LMS). The LMS was developed in the mid 1980s as a tool to assess the 
extent of CRS and facilitate treatment decisions (Lund and Mackay 1993). It is an objective 
measure of quantifying disease severity and is based on a simple numeric score derived 
from the CT scan. The interpretation of CT scan does not require radiology training and 
has a high inter-observer reliability.  
The scoring system for the sinus groups is based on their appearances on the CT scan. 
Each group of sinuses (maxillary, frontal, sphenoid, anterior ethmoid and posterior 
ethmoid) on each side is judged on radiological images to be completely clear, partly 
opaque or completely opaque, scoring 0, 1 and 2 points respectively. In addition, the degree 
of occlusion of the ostiomeatal complex in each side is judged as either not obstructed or 
obstructed, scoring 0 or 2. In total six sites are scored in each side, and the total score is the 
sum of scores from each side and ranges from 0 to 24, complete lucency of all sinuses to 










Table 6: The scoring system of LMS 
Anatomical site 
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Anatomically divided into 6 sites (Lund and Mackay 1993). Each side is graded separately. Radiological 
absence in all sites scores 0 and a maximum score of 24 is possible when all the anatomical sites are 
completely affected. In terms of ostiomeatal complex, grading according to opacity is not possible because of 
the size. Therefore obstruction versus not obstruction is used. Of note, an aplastic (absent) frontal sinus 
receives a score of 0. All patients were diagnosed with chronic rhinosinusitis according to the definition of 





The LMS has been shown to correlate with disease severity, the extent of sinus surgery and 
has been identified as a strong predictor of symptom levels after treatment (patients with 
higher pre-op severity on CT show significantly higher improvement in symptom scores) 
(Brook et al. 2017). The LMS has been proved to be practical and accurate in several 
studies and was recommended by the Task Force on Rhinosinusitis for use as a diagnostic 
tool in everyday clinical practice as well as for research (Lund and Mackay 1993). 
Based on the above recommendations we decided to use the LMS as it is currently the 
most accepted and widely used staging system, allowing comparison with other studies on 
CRS. In our study, CT scans of nasal sinuses were assessed independently by 2 physicians 
who are experienced in using LMS on CT scans (a radiologist who was blinded on the 
clinical presentation of the patient and an ENT surgeon). If there was a difference in the 
scoring of a CT scan between the two physicians, then the scan was discussed and a final 
consensus was reached. 
2.6 Asthma 
The presence of asthma was based on patient history revealing a diagnosis of asthma from 
a pulmonary physician or general practitioner and active prevention therapy with at least a 
beta-2 agonist at the time of presentation in our ENT clinic. 
2.7 Surgery 
The decision to operate was always taken on an individual basis taking into account the 
patients symptoms and clinical signs. All patients were treated for a minimum of three 
months with topical steroids, nasal saline irrigation and in several cases of CRSwNP oral 
steroids prior to surgery, as advised by the European Position Paper on Rhinosinusitis and 
Nasal Polyps 2012 (Fokkens et al. 2012). Surgical interventions were carried out once the 
medical management was proven to be ineffective. 
In all cases, FESS was performed aiming to restore sinus ventilation and remove foci of 
disease based on the concept of functional surgery of the nasal sinuses. The extent of 
surgery was based on the extent of sinus disease. The single steps encompass: uncinectomy 
with exposure and enlargement of the natural maxillary ostium, opening of the bulla 
ethmoidalis with access to the anterior and posterior ethmoid cells, improving the drainage 
pathway of the frontal sinus and dilatation of the access of the sphenoid sinus (Weber and 
Hosemann 2015). 
In our study, we recorded the number of operations performed in allergic and non-allergic 
patients. We identified postoperative complications and divided them into major 
complications which required a surgical intervention and minor complications which did 
not require surgery and were managed conservatively or medically. 
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We followed-up patients for 36 months after their initial operation and documented the 
need for a revision surgery due to recurrence of CRS. 
2.8 Ethical standards 
The study was approved by the University Hospital of Goettingen Ethics committee and 
was registered under the protocol number (DOK_88_2016 30062016, 12/7/16) 
2.9 Statistical Analysis 
For the following analysis the software STAT 14.1 (SAS; Cary, USA) was used and for the 
graphical representation the software Statistica 13.0 (TIBCO; Palo Alto, USA). Statistical 
analysis was performed using the Mann-Whitney test, two-sample t-test, chi-square test and 





938 consecutive patients were identified through electronic database searching who 
presented to our otorhinolaryngology clinic with rhinological symptoms within a four-year 
period (November 2012 to November 2016). 720 of these satisfied the inclusion criteria, 
and of these, 253 had a complete work-up including history taking, allergy testing, nasal 
endoscopy with 30-degree endoscope and a CT of the nasal sinuses available in electronic 
form in our database. Out of the 253, 195 patients satisfied the EPOS-2012 criteria for the 















Figure 1: Flow diagram showing patient-selection. 938 consecutive patients who were 
referred to our clinic with rhinological symptoms between November 2012 and November 
2016 were identified. After applying the inclusion and exclusion criteria, there were 195 
patients who satisfied the EPOS-2012 criteria and were included in our study. 
938 patients presenting for the first time with rhinological 




Satisfy the exclusion criteria 
Underwent a complete work-up 
including endoscopic examination,  














These 195 patients included in our study were analyzed in two groups, patients with a 
chronic rhinosinusitis without evidence of an allergy and patients with chronic 
rhinosinusitis and a diagnosis of an allergy. 
3.1 Patients with CRS without evidence of  an allergy 
There were a total of 115 patients with CRS without evidence of an allergy. 51 were female 
(44%) and 64 male (56%), with a mean age of 44.1 years (range: 18.0-79.1, SD: 16.66). The 
mean LMS was 6.28 (SD: 5.69) for the whole group, 6.82 (SD: 6.48) for females and 5.84 
(SD: 4.98) for males. 95 patients (82.6%) had a diagnosis of CRSsNP and 20 of CRSwNP 
(17.4%). 6 patients (5.2%) had a diagnosis of asthma (Table 7). 
None of the above 115 patients was previously operated prior to the presentation in our 
clinic. Following our diagnostic procedures, 65 patients (56.5%) were managed surgically 
with functional endoscopic sinus surgery and 60 medically with intranasal corticosteroids 
and daily saline irrigation.  
 
Table 7: Demographics and LMS of the 195 patients included in our study 
        Patients with CRS  
         without allergy 
        Patients with CRS  
         and allergy 
Total Number 115 80 
Age (years) 44.1 (range 18.0-79.1) 37.9 (range 18.2-79.8) 
Female 51 35 
Male 64 45 
Patients with CRSsNP 95 55 
Patients with CRSwNP 20 25 
LMS – total nos. patients 6.28 7.46 
LMS Female 6.82 6.74 
LMS Male 5.84 8.02 




3.2 Patients with CRS and diagnosis of  allergy 
There were a total of 80 patients with CRS and a diagnosis of an allergy. 35 were female 
(43.8%) and 45 male (56.3%), with a mean age of 37.9 years (range: 18.2-79.8, SD: 14.63). 
The mean LMS was 7.46 (SD: 6.28) for the whole group, 6.74 (SD: 5.60) for females and 
8.02 (SD: 6.77) for males. 55 patients (68.8%) had a diagnosis of CRSsNP and 25 of 
CRSwNP (31.3%). 18 patients (22.5%) had a diagnosis of asthma. 
44 patients (55%) had a single allergy: 19 (23.8%) to house dust mite, 16 (20%) to pollen of 
early blossoming plants, 7 (8.8%) to pollen of grass or rye, 1 (1.3%) to dog dander and 1 
(1.3%) to ragweed pollen. 36 patients (45%) had multiple allergies: 19 (23.8%) to both 
pollen and house dust mite, 10 (12.5%) to early and late blossoming pollen, 3 (3.8%) to 
both house dust mite and animal dander, 3 (3.8%) to early and late blossoming pollen, 
mite, fungi and animal dander and 1 (1.3%) to house dust mite and mold. 
When dividing the total number of 80 allergic patients into “seasonal allergy”, “perennial 
allergy” and “mixed allergy”, 34 (42.5%) had a seasonal allergy, 24 (30%) had a perennial 
allergy and 22 (27.5%) had a mixed allergy. After the diagnosis of allergy, 14 patients 
(17.5%) opted for allergen immunotherapy. 
None of the above 80 patients was previously operated prior to the presentation in our 
clinic. Following our diagnostic procedures, 52 patients (65%) were treated surgically; the 
rest did not undergo a surgical procedure.  
3.3 Statistical analysis 
We statistically analyzed several factors and parameters: 
3.3.1 Presence/absence of allergy and LMS in all patients 
We tested whether the presence or absence of an allergy had an effect on the LMS in all 
195 patients that were included in our study. There were 115 patients with CRS without an 
allergy and 80 patients with CRS with a diagnosis of allergy (Table 7). The mean LMS in 
the group without allergy was 6.28 and 7.46 in the group with a diagnosed allergy. Although 
the LMS was higher in the latter group, there was no statistical difference in the LMS when 




Figure 2: Comparison of LMS in 115 patients with CRS without an allergy and 80 patients 
with CRS and an allergy. There was no statistical difference in the LMS between the two 
groups. 
3.3.2 Presence/absence of allergy and LMS in patients with severe CRS 
To further investigate this relationship, we analyzed only patients with a severe CRS with a 
LMS of 10-24. This division into mild (LMS 1-3), moderate (LMS 4-9) and severe CRS 
(LMS 10-24) was based on previous studies by Bhattacharyya and Fried (2003) who 
assessed the diagnostic accuracy of the LMS. A total of 60 patients were included. 33 
patients hat CRSwNP and 27 patients CRSsNP. 33 patients (55%) had no allergy, 18 (30%) 
were male and 15 (25%) were female. The mean age was 46.9 years (SD: 15.8) and the 
mean LMS was 13.96 (SD: 4.13). 
27 (45%) patients had an allergy, 18 (30%) were male and 9 (15%) were female. The mean 
age was 40.03 (SD: 16.86) and the mean LMS was 14.74 (SD: 4.67) 
Similar to the first analysis that included all patients, in this patient subgroup with severe 
CRS, the presence of allergy did not significantly affect the severity of LMS (p-value = 




Figure 3: Comparison of LMS in 60 patients with severe CRS. 33 patients had severe CRS 
without an allergy and 27 with an allergy. There was no statistical difference in the LMS 
between the two groups. 
 
3.3.3 Presence/absence of allergy and LMS in patients with CRSwNP 
We next tested whether the presence or absence of allergy affects the CT-score in patients 
with chronic rhinosinusitis and nasal polyps (CRSwNP). There were a total of 45 patients, 
24 (53%) were male and 21 were (47%) female. The mean age of these patients was 42.4 
years and the mean LMS was 13.77 (SD 6.15). Within this group, 25 (56%) patients had an 
allergy, 15 (33.3%) were male and 10 (22.2%) were female. The mean LMS was 13.64 (SD: 
6.30). 20 patients had no allergy. 11 (24.4%) patients were female and 9 (20%) were male. 
The mean LMS was 13.95 (SD: 6.12). 
 
We tested whether there is a statistical significant difference in the LMS of patients with 
CRSwNP without allergy and CRSwNP and allergy. There was no statistical significance in 
the LMS when comparing the two groups of patients with nasal polyps (p-value = 0.87, 





Figure 4: Comparison of LMS in 45 patients with CRSwNP. 20 patients did not have an 
allergy and 25 had a diagnosis of an allergy. There was no statistical difference in the LMS 
between the two groups. 
 
3.3.4 Presence/absence of asthma and LMS in all patients 
We analyzed whether the presence of asthma affects the LMS. 24 patients with a diagnosis 
of asthma were identified within the total population of patients. Mean age was 41.5 years 
(SD: 16.80). 18 patients (75%) were allergic and only 6 patients (25%) had no diagnosed 
allergy. 13 patients (54.1%) were female and 11 (45.9%) were male. Patients with a 
diagnosis of asthma had a higher LMS (mean: 9.92, SD: 8.10) than patients without (mean: 
6.82, SD: 5.48). However, the difference was not statistically significant (p-value = 0.06, 




Figure 5: Comparison of LMS in 171 patients with CRS without asthma and 24 patients 
with CRS and a diagnosis of asthma. There was no statistical difference in the LMS 
between the two groups. 
 
3.3.5 Effect of gender on the LMS 
We statistically analyzed whether gender affected the LMS in all patients with CRS 
(CRSsNP and CRSwNP, allergic and non allergic).  
There were 109 male patients with a mean age of 42.33 (SD: 16.45). The mean LMS was 
6.74 (SD: 5.86). There were 86 female patients with a mean age of 40.63 (SD: 15.72). The 
mean LMS was 6.79 (SD: 6.11). There was no statistical significance in the LMS between 




Figure 6: Comparison of LMS between gender. There were 109 male and 86 female 
patients. There was no statistical difference in the LMS between the two groups. 
 
3.3.6 Type of allergy and the effect on LMS 
We tested whether the type of allergy affects the radiological severity of CRS. We divided 
the 80 patients with recorded allergies into three groups based on the type of allergy they 
were diagnosed with: seasonal allergy, perennial allergy and mixed allergy (both seasonal 
and perennial). 
34 patients (42.5%) had a seasonal allergy with either early tree or grass pollen. Within this 
group 20 patients were male and 14 were female. The mean LMS was 6.44 (SD: 5.19).  
24 patients (30%) had a perennial allergy with house dust mite, mold or dog/cat dander. 17 
patients were male and 7 were female. The mean LMS was 8.63 (SD: 6.87). 
22 patients (27.5%) had a mixed allergy. 14 patients were female and 8 were male. The 
mean LMS was 7.77 (SD: 7.15). 
There was no statistically significant difference in the LMS when dividing patients with 
allergy in three different groups (seasonal, perennial and mixed) (p-value = 0.59, Kruskal- 




Figure 7: Comparison of LMS of 80 patients with CRS and allergy according to the three 
different allergy groups (seasonal, perennial and mixed). There was no statistical difference 
in the LMS between the three groups. 
 
3.3.7 Asthma and the presence of allergy 
We examined the relationship between asthma and the presence of allergy and compared it 
to our non-allergic patients. There was a positive association between allergy and asthma 
(p-value < 0.001, chi-square test). Using the odds ratio test a value of 5.27 was calculated. 
This indicates that an allergic patient is 5.27 times more likely to have asthma than a patient 
with no allergy. 
 
3.3.8 LMS in the presence of perennial allergy compared to non-allergic patients 
We investigated whether the presence of perennial allergy, which has previously been 
shown to impact CRS more than any other type of allergy, affects the LMS. 24 patients 
with only a perennial allergy were identified (Mean LMS: 8.63, SD: 6.87) and were 
compared to all non-allergic patients (n=115, LMS: 6.28, SD: 5.69). There was no 
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statistically significant difference in the LMS between patients with no allergy and those 
with perennial allergy (p-value = 0.13, Mann-Whitney test). 
 
3.3.9 The effect of allergy on postoperative complications 
65 patients (56.5%) of the total group of non-allergic patients were operated. There were 4 
major complications that required revision surgery; 3 patients had postoperative bleeding 
and 1 patient had a skull base defect. There were 9 minor complications; 2 patients had 
mild postoperative bleeding and 7 patients had postoperative infections, which were treated 
medically/conservatively.  
52 patients (65%) of the total group of allergic patients were treated surgically. There were 
3 major complications that required revision surgery; all patients had postoperative 
bleeding. There were 6 minor complications; 2 patients had mild postoperative bleeding 
and 4 patients had postoperative infections, which were treated medically/conservatively. 
No statistically significant relationship between allergy and the presence of postoperative 
was identified (major complications, p-value = 0.46, chi-square test) (minor complications, 
p-value = 0.37, chi-square test). 
 
3.3.10 The effect of allergy on the need for a revision surgery 
Within 36 months after the operation, 9 patients out of the 52 patients with allergies 
(17.3%) required a revision surgery because of recurrent disease. In comparison to the 
above, only 4 out of the 65 non-allergic patients (6.2%) required revision surgery within the 
same time frame. We found that there is a statistically significant association between 
allergy and revision surgery (p-value = 0.03, chi-square test). Using the odds ratio test a 
value of 3.52 was calculated. This indicates that a patient with an allergy is 3.52 times more 
likely to have revision surgery than a patient with no allergy.  
 
3.3.11 The relationship between CRSwNP and asthma 
45 patients with CRSwNP were identified. 11 patients had a diagnosis of asthma. Within 
the group of 150 patients with CRSsNP only 13 patients had a diagnosis of asthma. 
Statistical analysis showed that the presence of polyposis significantly affected the presence 
of asthma (p-value = 0.005, chi-square test). To quantify the association, we used the odds 
ratio test and we found that a patient with polyposis is 3.41 times more likely to have 




3.3.12 The relationship between mean age at first presentation and mean age at 
first operation between the two groups 
 
We compared the mean age of the 115 patients without an allergy (44.1 years, SD: 16.70), 
with the 80 patients with an allergy (37.9 years, SD: 14.63). Statistical analysis showed a 
significant difference of the mean age of the two groups (p-value = 0.009, t-test). In our 
study, patients with an allergy were 7.2 years younger when presenting for the first time to 
our clinic with symptoms compared to patients without an allergy.  
A similar relationship was identified when comparing the mean age of patients who were 
operated between the two groups. The mean age at first operation for patients without an 
allergy was 42.2 years (SD: 14.62) and for those with an allergy was 37.5 years (SD: 14.55). 
This reveals that patients with an allergy were operated 4.7 years younger compared to 
those without an allergy. Statistical analysis showed a significant difference of the mean age 



















We are interested in the complex interplay between CRS and allergy. Our study aims to 
improve the understanding of the relative roles of perennial and seasonal allergens in 
chronic rhinosinusitis. We investigated 195 patients with CRS who were not previously 
operated and assessed whether the severity of their disease measured radiologically using 
the LMS was affected by various factors such as allergy, gender and the presence of 
asthma. In addition, we evaluated whether the presence of allergic rhinitis has an influence 
on the age of presentation, age of operation, the rate of complications and need for 
revision surgery.  
Patients with an allergy had a tendency to more severe CRS when measured radiologically 
by the LMS. However, this difference was not statistically significant. There was no 
statistically significant difference in the LMS when comparing patients with and without 
asthma. We also failed to find an association between gender and LMS. The type of allergic 
rhinitis did not appear to have a significant effect on the LMS. There was also no 
statistically significant relationship between allergic rhinitis and the presence of 
postoperative complications. In our study patients with an allergy presented earlier and 
received a FESS significantly younger than patients without an allergy. In addition, we 
found a positive association between the presence of allergic rhinitis and the necessity of a 
revision surgery. 
CRS is thought to begin with a transition from acute rhinosinusitis or rhinitis, which under 
recurrent insults in genetically susceptible individuals progresses to CRS. From then on, 
this state can evolve from periods of remission followed by relapse into the symptomatic 
state, characterized by persistent symptoms. The frequency, evolution rates and risk factors 
that promote such a transition have yet to be identified, but this theory may be used to 
explain the natural history of the various clinical phenotypes of CRS (Tan et al. 2013b). 
We hypothesized that allergy could be a driving force influencing this progression into 
CRS. We assumed that the repeated exposure to allergens reduces the threshold of 
response of the mucosa to other stimuli, increasing mucosal edema, unleashing an 
inflammatory cascade and promoting the transition to a chronic inflammatory state. 
Unlike CRS, atopy to respiratory allergens is directly implicated in the pathophysiology of 
other chronic inflammatory conditions of the airway tract such as asthma (Burrows et al. 
1989). Our results have also supported this association. In our study there was a positive 
association between allergy and asthma with allergic patients being 5.27 times more likely to 
have asthma than patients with no allergies.  
In terms of CRS the role of allergy is still controversial with contrasting results reported in 




4.1 Evidence of  a positive relation between allergy and CRS 
Several studies have reported much higher rates of sensitization to one or more perennial 
aeroallergens compared to our study, particularly dust mites in patients with CRS. 
Friedman (1975) demonstrated that 94% of adult patients who had undergone a 
sphenoethmoidektomy due to CRS were atopic.  
Unlike our results, which showed no significant relationship between the presence of 
allergic rhinitis and severity of CRS, several studies have identified a positive association 
between atopy and disease severity graded on CT scans. In 199 patients with CRS requiring 
FESS, the mean CT score of nasal sinuses using the LMS was significantly higher in the 
atopic patients than in non-atopic patients overall (14.2+/-1.6 versus 12.2+/-1.3; p-value = 
0.05), although within each clinical subdivision, no statistically significant relationship was 
detected between a patients' atopic status and their LMS (Robinson et al. 2006). 
Krouse et al. (2000) showed a significant correlation between CT score using the LMS 
system and sensitivity to allergens using the skin end point titration in 48 patients with 
chronic rhinosinusitis. Emanuel and Shah (2000) reported that the majority of patients 
(84%) presenting with persistent CRS requiring surgical treatment tested positive for 
allergies. These patients had evidence of disease on CT imaging. However, an interesting 
finding was the relatively lower percentage of allergy 69% in the group of patients with the 
most severe disease, compared to 83% and 88% respectively in the groups of patients with 
the mildest form of sinus disease on CT scans. 58% had multiple allergen sensitivities, and 
26% had sensitivity to a single allergen. There was a clear preponderance of perennial 
allergy reactivity over seasonal allergens in these patients with dust mite being the most 
common allergen (82%) amongst the group with single allergen sensitivity. In this study the 
type and degree of sensitivity of the allergen did not impact significantly on the grade of 
sinus disease severity based on CT scan opacification. 
Ramadan et al. (1999) published results from 42 patients with no prior surgical treatment 
presenting with symptoms of CRS. Allergic patients were found to have a higher LMS 
(mean score = 12) when compared to non-allergic patients (mean score = 6). A positive 
association between the presence of inhalant allergy and a statistically significant increase in 
the Lund Mackay score was shown by Batra et al. (2013) in 225 patients undergoing 
revision surgery for refractory chronic rhinosinusitis with/without polyps. In their study, 
the overall prevalence of inhalant allergy was 38.7% – a value much lower than similar 
studies. 
In another study by Houser and Keen (2008), a high prevalence of atopy (56,4%) was 
reported in a cohort of patients refractory to medical treatment undergoing surgery due to 
CRS, particularly perennial allergens. Their results indicated a significantly higher 
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prevalence of atopy amongst these patients compared to the general population (Bellanti 
and Wallerstedt 2000). However this study included patients with positive allergy testing 
without taking into account any clinical symptoms and relevant history suggesting allergy. 
In contrast, our study aimed to overcome this limitation and inconsistency shown by 
previous studies. We identified individuals as ‘allergic’ only when they had a history 
suggesting allergy, combined with a positive skin prick test and specific IgE and in several 
cases nasal provocation to differentiate patients with perennial allergies from those with 
CRS. 
Similar findings to Houser and Keen, with a very high incidence of sensitization to 
perennial allergens but not to seasonal allergens were reported in several other studies. 
Amongst 48 patients with CRS unresponsive to medical therapy that required surgical 
treatment, 57.4% had a positive allergy test (atopy), with the vast majority of 92% having 
sensitivity to one or more perennial allergens–most frequently, molds and dust mites 
(Gutman et al. 2004). Berrettini et al. (1999) compared the CT scans of 40 adult patients 
with perennial allergic rhinitis to 30 control subjects and found significantly higher 
incidence of sinusitis in the allergic group compared to the control group (67.5% versus 
33.4%). In our study, we specifically investigated whether the different type of allergy and 
particularly perennial allergy has an effect on the LMS. Within a group of 80 allergic 
patients, 24 had only a perennial allergy. The LMS of these patients was higher (8.63 
compared to 6.44 in the group of patients with seasonal allergies and 7.77 in the group with 
mixed allergies), however, there was no statistically significant difference in the LMS when 
comparing the three different groups (seasonal, perennial and mixed). 
The majority of authors from the above studies indicate that the high prevalence of 
atopy/allergy is thought to be a causative factor for CRS, as the constant inflammation in 
the nasal sinuses caused by (perennial) allergy leads a vicious cycle of poor mucociliary 
clearance, obstruction of the sinus ostia and thus development of CRS (Houser and Keen 
2008). Our study failed to show similar results which makes us wonder whether this a true 
representation or whether it is the result of a selection bias in several studies because of 





4.2 Support that allergy plays a role in CRSwNP and not in CRSsNP 
Some studies have shown a positive association between allergy and CRSwNP but not with 
CRSsNP. Asero et al. (2001) showed a 63% prevalence of positive skin prick test (but not 
significant history of allergy) in patients with nasal polyposis. The role of perennial 
respiratory allergens on CRSwNP was also investigated in the following study by Grigoreas 
et al. (2002). They showed that there was an increased frequency of CRSwNP in patients 
with a perennial respiratory allergy (rhinitis, asthma). 
We also examined whether the presence or absence of allergy affects the CT-score in 
patients with chronic rhinosinusitis and nasal polyps (CRSwNP). Unlike the above studies, 
we did not find a statistically significant relationship between LMS and the presence of 
CRSwNP. Comparable to our results Li et al. (2016) identified no association between 
atopy status and LMS in a prospective study involving 210 patients with CRSwNP. 
 
4.3 Evidence of  no association between allergy and CRS severity 
In our study, the mean LMS of patients with an allergy was higher compared to the LMS of 
patients without an allergy (7.46 vs 6.28). After our statistical analysis between the two 
groups we failed to find a significant association between the presence of allergy and the 
severity of CRS measured radiologically by the LMS. The same was true when comparing 
patients with severe CRS. Similar results were identified by various authors in the past. 
Settipane and Chafee (1977) found a negative correlation between allergy and CRSwNP. In 
their study the most severe polyposis was identified in patients with a negative skin prick 
test. However, at the time no CT diagnostic evaluation of the sinuses was performed and 
the assessment of polyposis was made only on clinical examination. In a study of 2,200 
Italian children evaluated for chronic respiratory symptoms, sensitization to at least one 
inhalant allergen by skin test and detection of high total IgE was 29.9%, with no positive 
association between aeroallergen sensitization and chronic sinusitis. Authors concluded 
that the prevalence of sensitization to respiratory allergens in children with chronic sinusitis 
is comparable with that of the general pediatric population (Leo et al. 2007).  
Tan et al. (2011) reviewed 125 patients failing medical therapy for CRS and found no 
significant correlation between atopy and LMS, or the influence of sensitivity to any single 
allergen on CRS disease severity. 82.4% of these patients were identified as atopic, a rate 
much higher compared with the general population. The authors of the above study 
suggested that these high rates of atopy, which were also observed in other studies of 
similar design, were due to referral patterns and referral biases resulting in an 
overrepresentation of allergic patients.  
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Pearlman et al. (2009) investigated the relationship between the severity of CRS measured 
by the LMS and found no statistical relationship between LMS and atopic status in the 
entire group. 
A study published in 2017, which is one of the biggest studies up to date with 437 patients 
with CRS, failed to show a positive association between atopy and CRS in patients with 
allergic sensitization. The mean LMS did not significantly differ between 251 patients with 
a positive in vitro allergen test and 186 patients with a negative test (Brook et al. 2017). The 
two most recent studies by Hamizan et al. (2018) and Shen et al. (2019) which compared 
patients with CRS with and without allergies also failed to identify a positive correlation 
between allergy and LMS. Hamizan et al. investigated the central radiological pattern of 
mucosal disease in patients with inhalant allergen sensitization and found no statistically 
significant difference in the LMS between 49 non-atopic patients and 63 allergen-sensitized 
patients. However, they reported that the central radiological pattern of mucosal disease in 
all the paranasal sinuses was statistically associated with inhalant allergen sensitization. Shen 
et al. (2019) investigated 138 CRS patients who underwent endoscopic sinus surgery and 
showed that the LMS was not significantly different between the allergic and non-allergic 
group. 
 
4.4 Association between allergy and revision surgery 
In our study we found a positive association between allergy and the need for revision 
surgery. Similar results were published in several other studies. In a large study, which 
included 29,934 patients with a mean length of follow-up of 9.7 years after a FESS, the 
long-term revision rate was found to be 15.9%. Amongst other factors which included 
nasal polyps, comorbid asthma, and female gender, allergy was also identified as a 
significant factor increasing the risk of revision surgery (Smith et al. 2019). 
Calus et al. (2019) showed that allergic sensitization is a significant risk factor predicting the 
need for revision surgery in a long-term prospective study which included patients with 
CRSwNP with a follow-up time of 12 years. Comparable results have been shown in the 
pediatric population. In a retrospective review by Wu et al. (2020) nasal allergy was 
identified as significant risk factor for revision surgery. 
This relationship has not been identified in various other publications. Batra et al. (2013) 
investigated 225 patients with refractory chronic rhinosinusitis and indicated a higher 




4.5 Association between allergy and asthma 
We analyzed the relationship between asthma and the presence of allergy in our study and 
compared it to our non-allergic patients. There was a statistically significant positive 
association between allergy and asthma. Within our cohort, a patient with allergic rhinitis is 
5.3 times more likely to have asthma than a patient with no allergy. This is consistent with 
published literature in the last 20 years from large epidemiological studies indicating that 
allergic rhinitis is one of the most significant risk factors for the development of asthma 
(Annesi-Maesano 1999; Tan et al. 2013b). We are currently aware that the respiratory tract 
is a single continuous functional entity with common pathological mechanisms acting in 
the nose/nasal sinuses and in the bronchi. 
 
4.6 Association between CRSwNP and asthma 
Similar to the above findings, our study identified a statistically significant relationship 
between CRSwNP and the presence of asthma. In our study, a patient with nasal polyps is 
3.4 times more likely to have asthma than a patient without. This has been documented in 
the past with studies confirming the prevalence of asthma in up to 48% of patients with 
CRSwNP in comparison to 16% in patients with CRSsNP (Promsopa et al. 2016). 
 
4.7 Association between allergy and postoperative complications 
Analysis of major and minor postoperative complications in our patients undergoing 
functional endoscopic sinus surgery did not identify a significant association between 
allergy and the risk of developing postoperative complications. This has been previously 
investigated and reported similarly by other authors. Chou et al. (2016) reported 7.8% of 
postoperative complications in 997 patients, which is in line with our results. They 
identified high polyp grading (Grades 2 and 3), inexperienced surgeon and the use of 
powered instruments as risk factors for the development of complications. Asaka et al. 
(2012) identified Asthma and CRSwNP as risk factors. In their study, patients with an 
allergy did not appear to have a statistically significant higher risk for the development of 
postoperative complications. 
 
4.8 Revision surgery 
The rate of revision surgery after functional endoscopic sinus surgery can range according 
to the population under study, the subtype of CRS and the follow-up time. However, in a 
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large prospective cohort study, with 1459 patients followed-up for 5 years, the rate of 
revision surgery approached 20% (Hopkins et al. 2009). In our investigation, within 36 
months of follow-up, we recorded in total 11.1% revision rate. Revision surgery was 
required in 17.3% of patients with an allergy compared to 6.2% of patients without an 
allergy. Analysis of the above results showed a statistically significant relationship between 
allergy and the need for revision surgery. 
In the past, controversial results have been published regarding the role of allergy on the 
rate of revision surgery, with the majority of authors finding no significant association 
between allergy and the need for revision surgery. Robinson et al. (2006) reported no 
significant difference in the rate of revision surgery between atopic and non-atopic patients 
in a prospective study that included 193 consecutive patients with CRS. Koskinen et al. 
(2016) followed 178 patients retrospectively for 5 years and identified allergic rhinitis as a 
significant factor associated with the need for revision surgery. 
 
4.9 Age at first presentation, first operation and disease progression 
We analyzed whether allergy has an influence on the age of patients seeking medical 
treatment at our tertiary otorhinolaryngology center. Our findings indicated that patients 
with an allergy were 7.2 years younger (37.9, SD: 14.63) at the time of first presentation 
compared to patients without an allergy (44.1 years, SD: 16.70). We also compared the 
mean age of patients who were operated between the two groups. We found that patients 
with an allergy were operated on average 4.7 years younger (37.5, SD: 14.55) compared to 
those without an allergy (42.2 years, SD: 14.62).  
A similar finding was reported by Shen et al. (2019) who reported that the mean age of 
those receiving endoscopic sinus surgery was 7 years younger in the allergic, compared to 
the non-allergic group (42.8 ± 15.3 years versus 49.8 ± 15.8 years, p-value = 0.008). Similar 
to our study, the LMS scores were not significantly different between the two groups. 
However, in this study from Taiwan, 90% of patients had allergies to house dust mites and 
none had allergies to grass/pollen, something unusual and by no means similar to the 
distribution of allergies within our cohort.  
Based on their results, Shen et al. (2019) have indicated that allergy may accelerate disease 
progression in CRS. To date there have been no other studies indicating such a relationship 
between the presence of allergy and the earlier onset of symptoms and need for a surgical 
intervention. It is difficult to ascertain whether allergy truly accelerates disease progression 




4.10 Allergy, atopy and inconsistencies in previous studies 
The terms “atopy” and “allergy” are often used inconsistently in scientific literature 
especially in studies of allergic rhinitis. Studies have often included patients with atopy or 
just sensitized patients based on a skin prick test or specific IgE detection, without taking 
into account the clinical symptoms or performing a nasal provocation test. Many published 
reports have therefore assessed the relationship between atopy and chronic rhinosinusitis 
rather than allergic rhinitis. 
Our study is one of the few studies to compare severity of CRS based on the LMS in 
patients with a diagnosed allergy based on thorough allergy investigations, to patients with 
no allergy. All our patients have been identified as “allergic” only after having a positive 
history of allergic rhinitis, having a positive skin prick test, detection of specific IgE and in 
23 patients also performing a nasal provocation test. 
Previous studies have included patients as allergic after having only a positive in vitro 
allergen test (Ramadan et al. 1999; Robinson et al. 2006; Brook et al. 2017), with just a 
positive skin prick test (Berrettini et al. 1999; Pearlman et al. 2009), with either in vitro 
testing or skin prick test (Emanuel und Shah 2000; Batra et al. 2013; Hamizan et al. 2018), 
with only skin end-point titration test (Krouse 2000), with in vitro testing or skin end-point 
titration (Gutman et al. 2004), with a mixture of skin prick tests, intradermal dilutional test 
und in vitro test (Houser and Keen 2008). Only one study (Tan et al. 2011) included 
patients with a positive history, evaluated them using standard skin prick test and 
intradermal testing when skin prick was negative. Therefore, many of the above patients 
which have been included in the above studies are by definition atopic/sensitized to 
allergens but not allergic. We also conducted one of the few studies to include patients only 






4.11 Possible mechanism – local inflammatory pathway 
One might wonder why allergy, which impairs normal sinus physiology and promotes 
inflammation, does not predispose or exacerbate CRS in an obvious way. A number of 
authors have suggested that CRS is an inflammatory disease that occurs independently of 
systemic IgE-mediated pathways. Significant levels of mucosal IgE, eosinophils and Th2 
cytokines have also been shown to be present in nonatopic patients (Carney et al. 2006). 
In addition, authors have identified patients with persistent sinonasal symptoms, negative 
skin prick tests and positive nasal provocation tests with raised local production of IgE 
antibodies (Rondón et al. 2007). There is evidence that elevated levels of local IgE and 
activation of mast cells and eosinophils in nonatopic patients occurs directly by local 
microorganisms without allergy being the direct causative agent (Terzakis and Georgalas 
2017). The possible explanation for this to occur is IgE formation induced by 
superantigens including staphylococcal enterotoxins A and B. These mucosally formed IgE 
are functional, even in the absence of systemic IgE or positive skin test (Matsuwaki et al. 
2013). This implies that there is no direct route leading from allergy to the development of 
CRS but rather a common pathway.  
The effect of IgE is interesting as patients with negative allergy tests and no obvious 
sensitization to aeroallergens seem to also benefit from an IgE binding therapy 
(Omalizumab). However a recent systematic review on the use of anti-IgE monoclonal 
therapy for the treatment of chronic rhinosinusitis based on two randomized controlled 
trials did not show sufficient effectiveness of anti-IgE in the treatment of CRS (Hong et al. 
2015). Local IgE levels might play a significant role and constitute an important mechanism 
in nonallergic inflammation, producing some of the variable clinical effects seen in allergen 
avoidance and allergen immunotherapy. 
Maybe allergy is a disease-modifying factor in CRS, as proposed by different authors 
(Terzakis and Georgalas 2017). This idea could account for our results. Although disease 
severity did not appear to be significantly influenced by the presence of allergy, allergy 
might accelerate disease progression resulting in patients presenting earlier and 
predisposing them to a worst clinical outcome postoperatively, thus resulting in higher 






The first limitation of our study arises from the fact that we have grouped our cohort of 
patients with CRS based on the EPOS guidelines, only into the 2 traditionally accepted 
subdivisions – CRSwNP and CRSsNP. This description relies on observable clinical 
findings but fails to include immunopathological mechanisms. There is increasing evidence 
that CRS encompasses a complex group of immunopathological distinct disorders with 
several clinical phenotypes. In a multicenter study by Tomassen et al. (2016) 10 different 
endotypes were identified using cluster analysis of biomarkers. Inflammation in CRS is 
more diverse than previously thought and this of course has significant influences on 
research regarding CRS and allergy. Endotyping patients within these phenotypes could be 
the key in understanding the complex immunology and drawing more correct conclusions 
regarding the effect of allergy on the disease. However, the use of inflammatory endotyping 
is currently at an early experimental level that has not been tested and is still not used in 
everyday clinical practice. 
The second limitation involves the use of the LMS system as a measure of CRS disease 
severity, a scoring system that is by no means perfect. The major limitation arises from the 
fact that the LMS scores any partial opacification identically, giving it 1 point, thereby 
attributing equal values to both the presence of 20% opacification and 60% opacification, 
which have different clinical outcomes. Secondly, it has been shown by some authors that 
there is no association between LMS and subjective disease severity (symptoms) as well as 
quality of life (Hopkins et al. 2007). 
The third limitation that should be acknowledged is that the timing of CT scan of the nasal 
sinuses has not been taken into account in our study. This means that patients with a 
seasonal allergy could potentially have a significantly worse LMS during the allergy season 
compared to other times, thus influencing the study results. 
Finally, our study is a retrospective study, carrying all the limitations of retrospective 
studies such as selection and information bias. However, as far as we are aware, there are 










The role of allergic rhinitis as a causative immunopathological factor in chronic 
rhinosinusitis is controversial despite extensive investigation in the last 20 years. To further 
explore this relationship, we conducted a retrospective analysis of patients with chronic 
rhinosinusitis. 
A total of 938 consecutive cases between November 2012 and November 2016 were 
analyzed. In our study we included 195 patients referred to our university-based allergy and 
sinus clinic with chronic rhinosinusitis who were not previously operated. All these patients 
were thoroughly investigated with computed tomography scan, skin-prick testing, total and 
specific serum IgE measurements and nasal provocation. We recorded demographic data 
and scored the severity of sinus disease in computed tomography scans using the Lund 
Mackay Score.  
There were a total of 115 patients with chronic rhinosinusitis without evidence of an allergy 
based on a negative skin prick and serum IgE measurements and 80 patients with chronic 
rhinosinusitis and allergic rhinitis. There was no statistical significance in the Lund Mackay 
Score when comparing the two groups and the presence of asthma. The type of allergic 
rhinitis (seasonal, perennial, mixed) did not have a significant effect on the Lund Mackay 
Score. There was no statistical significance between allergic rhinitis and the presence of 
postoperative complications (major and minor complications). We found a statistically 
significant association between allergic rhinitis and the necessity of revision surgery (p = 
0.0324) as well as a positive association between the presence of asthma and allergy (p = 
0.0003). Allergic patients with chronic rhinosinusitis presented 7.2 years earlier to our 
otorhinolaryngology clinic and were 4.7 years younger at time of operation compared to 
those without an allergy, both values found to be statistically significant. 
Our results show a limited association between CRS severity and allergy status. However, 
in our study, patients with chronic rhinosinusitis and allergic rhinitis tended to present 
earlier, be operated at a younger age and have worst postoperative clinical outcomes 
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